theravance inc (THRX:NASDAQ GS)
Rick E. Winningham
Former Chairman of the Board, Member of Stock Option Committee and Member of Science & Technology Advisory Committee, Theravance Inc.
|Age||Total Calculated Compensation||This person is connected to 63 board members in 4 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Rick E. Winningham was the Chief Executive Officer of Theravance Inc. since October 2001 until August 15, 2014. Mr. Winningham served as President of Theravance Inc. since October 2001. From 1997 to 2001, Mr. Winningham served as the President, Bristol-Myers Squibb Oncology /Immunology /Oncology Therapeutics Network (OTN) and as the President of Global Marketing from 2000 to 2001. In addition to operating responsibility for U.S. Oncology/Immunology/OTN at Bristol-Myers ...
951 Gateway BoulevardPhone: 650-238-9600
South San Francisco, California 94080
Board Members Memberships*
Former Chairman of the Board, Member of Stock Option Committee and Member of Science & Technology Advisory Committee
Lead Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Texas Christian University
Southern Illinois University, Carbondale Campus
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Rajat Rai||Chief Executive Officer|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Carolyn J. Logan||Chief Executive Officer, President and Director|
Salix Pharmaceuticals Ltd.
|$867.5K||Compensation as of Fiscal Year 2013.|